Gilead Sciences (GILD) Q4 2025 (USD): EPS 1.86 (exp. 1.81), Revenue 7.93bln (exp. 7.69bln)

Gilead Sciences reported better-than-expected Q4 earnings with EPS of 1.86 against expectations of 1.81, indicating strong operational performance.

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

Ford Motor Company (F) Q4 2025 (USD): Adj. EPS 0.13 (exp. 0.18), Revenue 45.9bln (exp. 43.60bln)

US President Trump thinks 2026 is going to be great - pre-recorded Fox Business interview

Gilead Sciences (GILD) Q4 2025 (USD): EPS 1.86 (exp. 1.81), Revenue 7.93bln (exp. 7.69bln)

US weighs seizing tankers carrying Iranian oil to pressure Tehran, WSJ reports

Morgan Stanley (MS) expects the rollout and refinement of advanced “Agentic AI” solutions to continue as a major productivity driver throughout 2026 and beyond, moving from information retrieval to autonomous execution

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Raised quarterly dividend by 3.8% to 0.82/shr from 0.79.

Outlook

  • FY26 non-GAAP EPS 8.45-8.85 (exp. 8.79).
Context

The raised dividend reflects management's confidence in cash flows and future growth, while the FY26 EPS guidance also exceeds expectations, suggesting a positive outlook for the company's performance moving forward.

Related headlines

The whole workspace, free to try.

Try it free